NovaBay Pharmaceuticals, Inc. — All Filings
1,002 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
5
5/A
8-A12B
8-K
8-K/A
ARS
CERTAMX
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
EFFECT
FWP
NT 10-K
POS AM
POS EX
PRE 14A
PREM14A
PRER14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001437749-26-009301 | Mar 23, 2026 | — |
| 10-K | FORM 10-K | 0001437749-26-009090 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001437749-26-008015 | Mar 12, 2026 | — |
| SCHEDULE 13D/A | — | 0001398344-26-005034 | Mar 11, 2026 | — |
| DEFA14A | FORM DEFA14A | 0001437749-26-006407 | Mar 2, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-004922 | Feb 20, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-003846 | Feb 12, 2026 | Feb 11, 2026 |
| DEF 14A | FORM DEF 14A | 0001437749-26-003571 | Feb 10, 2026 | Mar 12, 2026 |
| 8-K | FORM 8-K | 0001437749-26-002586 | Jan 30, 2026 | — |
| PRE 14A | FORM PRE 14A | 0001437749-26-002582 | Jan 30, 2026 | Mar 12, 2026 |
| SCHEDULE 13D/A | — | 0001829126-26-000773 | Jan 29, 2026 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-26-000165 | Jan 29, 2026 | Oct 21, 2025 |
| 8-K | FORM 8-K | 0001437749-26-002309 | Jan 28, 2026 | Jan 22, 2026 |
| D | — | 0001389545-26-000001 | Jan 27, 2026 | — |
| SCHEDULE 13D/A | — | 0001437749-26-001671 | Jan 21, 2026 | — |
| SCHEDULE 13D/A | — | 0001437749-26-001670 | Jan 21, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-001490 | Jan 20, 2026 | — |
| 424B5 | FORM 424B5 | 0001437749-26-001489 | Jan 20, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-001459 | Jan 16, 2026 | — |
| EFFECT | — | 9999999995-25-003396 | Nov 26, 2025 | — |
| S-8 | FORM S-8 | 0001437749-25-036357 | Nov 25, 2025 | — |
| S-3/A | FORM S-3/A | 0001437749-25-036354 | Nov 25, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-033852 | Nov 7, 2025 | Sep 30, 2025 |
| 4 | FORM 4 | 0001437749-25-032856 | Nov 3, 2025 | Oct 16, 2025 |
| 4 | FORM 4 | 0001437749-25-032855 | Nov 3, 2025 | Oct 16, 2025 |
| 4 | FORM 4 | 0001437749-25-032854 | Nov 3, 2025 | Oct 16, 2025 |
| 4/A | FORM 4A | 0001829126-25-008355 | Oct 22, 2025 | Oct 16, 2025 |
| 3/A | FORM 3A | 0001829126-25-008354 | Oct 22, 2025 | Oct 9, 2025 |
| 8-K | 8-K | 0001829126-25-008338 | Oct 22, 2025 | Oct 16, 2025 |
| 8-K | 8-K | 0001829126-25-008295 | Oct 21, 2025 | Oct 20, 2025 |
| SCHEDULE 13D/A | — | 0001829126-25-008291 | Oct 20, 2025 | — |
| SCHEDULE 13D/A | — | 0001829126-25-008290 | Oct 20, 2025 | — |
| 4 | FORM 4 | 0001829126-25-008289 | Oct 20, 2025 | Oct 16, 2025 |
| 4 | FORM 4 | 0001829126-25-008288 | Oct 20, 2025 | Oct 16, 2025 |
| 4 | FORM 4 | 0001829126-25-008287 | Oct 20, 2025 | Oct 16, 2025 |
| 3 | FORM 3 | 0001829126-25-008286 | Oct 20, 2025 | Oct 16, 2025 |
| 3 | FORM 3 | 0001829126-25-008285 | Oct 20, 2025 | Oct 9, 2025 |
| 3 | FORM 3 | 0001829126-25-008284 | Oct 20, 2025 | Oct 9, 2025 |
| 8-K | 8-K | 0001829126-25-008237 | Oct 20, 2025 | Oct 16, 2025 |
| SCHEDULE 13D/A | — | 0001829126-25-008213 | Oct 17, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-25-002764 | Oct 17, 2025 | Oct 16, 2025 |
| SCHEDULE 13D/A | — | 0001398344-25-019284 | Oct 17, 2025 | — |
| SCHEDULE 13D | — | 0001829126-25-008156 | Oct 15, 2025 | — |
| SCHEDULE 13D | — | 0001829126-25-008155 | Oct 15, 2025 | — |
| DEFA14A | DEFA14A | 0001829126-25-008001 | Oct 9, 2025 | — |
| 8-K | 8-K | 0001829126-25-007992 | Oct 9, 2025 | — |
| S-3 | S-3 | 0001829126-25-007885 | Oct 3, 2025 | — |
| DEF 14A | DEF 14A | 0001829126-25-007608 | Sep 23, 2025 | Oct 16, 2025 |
| ARS | ARS | 0001829126-25-007607 | Sep 23, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001829126-25-007498 | Sep 18, 2025 | — |